StockData
BioStem Technologies, Inc. logo

BioStem Technologies, Inc. (BSEM) stock

BSEMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$0.64−0.07 (-10.23%)

Close on Nov 20, 2026Market cap $11.34MP/E –Yield –

Key statistics

Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026

Valuation

Market cap
$11.34M
P/E ratio
–
Price to sales
–
Price to book
0.41
Dividend yield
–
Free cash flow yield
–

Fundamentals

Book value per share
$1.59
Diluted shares
17M

Trading

Previous close
$0.71
Open
$0.70
Day's range
$0.53 – $0.71
Volume
254,255
Average volume (20 days)
296,005
Beta (5 years)
0.55
52-week range
$0.53 – $8.40
RSI (14 days)
26.6
Volatility (1 year)
128.3%
Relative volume
1.54×
WACC
7.8%

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 20, 2026. The S&P 500 is measured by the SPY fund.

PeriodBSEMS&P 500DifferenceBSEM per yearS&P 500 per year
1 month-61.3%-10.3%−51.0 pts
3 months-82.7%-9.3%−73.4 pts
Year to date-83.3%+1.9%−85.3 pts
1 year-83.5%+6.9%−90.4 pts
3 years-78.8%+57.5%−136.3 pts-40.4%+16.3%
5 years-25.3%+57.3%−82.6 pts-5.7%+9.5%
10 years-93.7%+269.7%−363.4 pts-24.2%+14.0%

Two years at a glance

Fiscal years 2024 to 2025, USD

Reported period

Press releases

Releases BioStem Technologies filed with the SEC as exhibits to Form 8-K or 6-K

BioStem Technologies stock: common questions

What is BioStem Technologies's stock price?

BSEM closed at $0.64 on Nov 20, 2026, down 10.23% on the day. Over the past 52 weeks it traded between $0.53 and $8.40.

What is BioStem Technologies's market cap?

BioStem Technologies was worth $11.34M at the close on Nov 20, 2026: the share price times the diluted shares outstanding.

Does BioStem Technologies pay a dividend?

No. BioStem Technologies has not paid a cash dividend over the last twelve months.

How has BSEM stock performed over the past year?

Including dividends, BSEM returned -83.5% over the past year, against +6.9% for the S&P 500.

How many BSEM shares are sold short?

0M shares were sold short at the latest FINRA report, 2.83% of the float, or 1.5 days of average trading volume.

Who are BioStem Technologies's competitors?

Companies most similar to BioStem Technologies by business, industry and size include AMGN, GILD, MRNA, BIIB, BNTX.

See a number that looks wrong?